Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1981 Nov;194(5):592–601. doi: 10.1097/00000658-198111000-00007

In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.

G M Stuhlmiller, D C Sullivan, C E Vervaert, B P Croker, C C Harris, H F Seigler
PMCID: PMC1345264  PMID: 6895297

Abstract

Specific in vivo localization of antibodies reactive with human melanoma cell membrane tumor associated antigens (TAA) has been attempted using congenitally athymic nude mice bearing subcutaneous human melanoma tumor xenografts as the experimental model. IgG fractions were prepared from each of several immune and control sera. Antimelanoma antibody sources included human alloantibody obtained from melanoma patients immunized against allogeneic melanoma cells, a monkey antiserum raised by immunization against a single human melanoma cell line, and a murine monoclonal antimelanoma antibody-secreting hybridoma cell line. Localization of these radiolabeled antibodies and of control IgG preparations to tumor tissue was determined by whole body scintigraphy and by differential tissue counting. Compared with the different control IgG preparations, each of the antimelanoma IgG preparations exhibited significant specific accumulation within the melanoma tissue. However, variation existed in the ability of each antimelanoma IgG to tumor preparation to localize despite attempts to control model parameters such as tumor source, in vivo passage number and mass. This variation appears to reflect basic biologic differences between tumors in different animals and possibly differences in the antigen-binding capacities of each IgG preparation following radioiodination. This technique for tumor localization is very promising and has obvious potential for clinical application.

Full text

PDF
592

Images in this article

596Figs. 4-9.
on p.596
597Fig. 10.
on p.597
599Fig. 12.
on p.599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carey T. E., Takahashi T., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278–3282. doi: 10.1073/pnas.73.9.3278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ghose T., Norvell S. T., Guclu A., Cameron D., Bodurtha A., MacDonald A. S. Immunochemotherapy of cancer with chlorambucil-carrying antibody. Br Med J. 1972 Aug 26;3(5825):495–499. doi: 10.1136/bmj.3.5825.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HIRAMOTO R., YAGI Y., PRESSMAN D. Immunohistochemical studies of antibodies in anti-Murphy lymphosarcoma sera. Cancer Res. 1959 Sep;19:874–879. [PubMed] [Google Scholar]
  4. Herlyn M., Steplewski Z., Herlyn D., Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438–1442. doi: 10.1073/pnas.76.3.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hunter R. Standardization of the chloramine-T method of protein iodination. Proc Soc Exp Biol Med. 1970 Mar;133(3):989–992. doi: 10.3181/00379727-133-34611. [DOI] [PubMed] [Google Scholar]
  6. Kilpatrick R. J., Seigler H. F. Specific cytotoxic antibody in the sera of patients with melanoma. J Surg Res. 1976 Nov;21(5):301–305. doi: 10.1016/0022-4804(76)90041-x. [DOI] [PubMed] [Google Scholar]
  7. Koprowski H., Steplewski Z., Herlyn D., Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3405–3409. doi: 10.1073/pnas.75.7.3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Liao S. K., Kwong P. C., Thompson J. C., Dent P. B. Spectrum of melanoma antigens on cultured human malignant melanoma cells as detected by monkey antibodies. Cancer Res. 1979 Jan;39(1):183–192. [PubMed] [Google Scholar]
  9. Metzgar R. S., Bergoc P. M., Moreno M. A., Seigler H. F. Brief communication: melanoma-specific antibodies produced in monkeys by immunization with human melanoma cell lines. J Natl Cancer Inst. 1973 Apr;50(4):1065–1068. doi: 10.1093/jnci/50.4.1065. [DOI] [PubMed] [Google Scholar]
  10. Mutzner P. A., Stuhlmiller G. M., Seigler H. F. Characterization of melanoma cell membrane tumor-associated antigens using xenoserum, alloserum, and autoserum: I. immunofluorescence. J Surg Oncol. 1980;14(4):367–377. doi: 10.1002/jso.2930140411. [DOI] [PubMed] [Google Scholar]
  11. PRESSMAN D., KORNGOLD L. The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies. Cancer. 1953 May;6(3):619–623. doi: 10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  12. Seigler H. F., Cox E., Mutzner F., Shepherd L., Nicholson E., Shingleton W. W. Specific active immunotherapy for melanoma. Ann Surg. 1979 Sep;190(3):366–372. doi: 10.1097/00000658-197909000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stuhlmiller G. M., Mohanakumar T., Metzgar R. S., Seigler H. F. The use of non-human primates for production of antisera to human tumor-associated antigens. J Immunol Methods. 1976;12(3-4):267–274. doi: 10.1016/0022-1759(76)90048-x. [DOI] [PubMed] [Google Scholar]
  14. Stuhlmiller G. M., Seigler H. F. Characterization of a chimpanzee anti-human melanoma antiserum. Cancer Res. 1975 Aug;35(8):2132–2137. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES